High‐Throughput Screening of Surface Engineered Cyanine Nanodots for Active Transport of Therapeutic Antibodies into Solid Tumor

Abstract

AbstractThe successful delivery of therapeutic biomacromolecules into solid tumor holds great challenge due to their high resistance to penetrate through the complex tumor microenvironments. Here, active‐transporting nanoparticles are harnessed to efficiently deliver biomacromolecular drugs into solid tumors through cell transcytosis. A series of molecularly precise cyanine 5‐cored polylysine G5 dendrimers (Cy5 nanodots) with different peripheral amino acids (G5‐AA) is prepared. The capability of these positively charged nanodots to induce cell endocytosis, exocytosis, and transcytosis is evaluated via fluorescence‐based high‐throughput screen. The optimized nanodots (G5‐R) are conjugated with αPD‐L1 (a therapeutic monoclonal antibody binding to programmed‐death ligand 1) (αPD‐L1‐G5‐R) to demonstrate the nanoparticle‐mediated tumor active transport. The αPD‐L1‐G5‐R can greatly enhance the tumor‐penetration capability through adsorption‐mediated transcytosis (AMT). The effectiveness of αPD‐L1‐G5‐R is tested in treating mice bearing partially resected CT26 tumors, mimicking the local immunotherapy of residual tumors post‐surgery in clinic. The αPD‐L1‐G5‐R embedded in fibrin gel can efficiently mediate tumor cell transcytosis, and deliver αPD‐L1 throughout the tumor, thereby enhancing immune checkpoint blockade, reducing tumor recurrence, and significantly prolonging the survival time. The active‐transporting nanodots are promising platforms for efficient tumor delivery of therapeutic biomacromolecules.